ECSP055895A - PHARMACEUTICAL ALLERGEN PRODUCT - Google Patents

PHARMACEUTICAL ALLERGEN PRODUCT

Info

Publication number
ECSP055895A
ECSP055895A EC2005005895A ECSP055895A ECSP055895A EC SP055895 A ECSP055895 A EC SP055895A EC 2005005895 A EC2005005895 A EC 2005005895A EC SP055895 A ECSP055895 A EC SP055895A EC SP055895 A ECSP055895 A EC SP055895A
Authority
EC
Ecuador
Prior art keywords
dosage forms
allergen
allergen product
pharmaceutical
rapid dispersion
Prior art date
Application number
EC2005005895A
Other languages
Spanish (es)
Inventor
Christian Gauguin Houghton
Annette Rommelmayer Lukdegaard
Henrik Hugo Jacobi
Olsen Stig Aasmul
Lise Lund Maerkedahl
Jan Sondergaard Andersen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of ECSP055895A publication Critical patent/ECSP055895A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
    • Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención proporciona productos farmacéuticos que contienen alérgeno y en particular formas sólidas de dosis de alérgeno, de dispersión rápida. En particular, se proporcionan formas sólidas de dosis, no comprimidas, de dispersión rápida, adecuadas para la administración oromucosa, que comprende una matriz y al menos un alérgeno. Las matrices adecuadas son gelatina, almidón y manitol. También se proporcionan métodos para las formas de dosis.The invention provides pharmaceutical products containing allergen and in particular solid dosage forms of allergen, rapid dispersion. In particular, solid, non-compressed, rapid dispersion dosage forms suitable for oromucosal administration are provided, comprising a matrix and at least one allergen. Suitable matrices are gelatin, starch and mannitol. Methods for dosage forms are also provided.

EC2005005895A 2002-11-26 2005-06-24 PHARMACEUTICAL ALLERGEN PRODUCT ECSP055895A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200201825 2002-11-26

Publications (1)

Publication Number Publication Date
ECSP055895A true ECSP055895A (en) 2006-09-18

Family

ID=35964203

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005895A ECSP055895A (en) 2002-11-26 2005-06-24 PHARMACEUTICAL ALLERGEN PRODUCT

Country Status (4)

Country Link
CN (1) CN1731979B (en)
EC (1) ECSP055895A (en)
UA (1) UA93479C2 (en)
ZA (1) ZA200505111B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008152067A1 (en) * 2007-06-12 2008-12-18 Alk-Abelló A/S An allergen dosage form comprising an antihistamine
JP5800527B2 (en) * 2010-03-30 2015-10-28 日東電工株式会社 Stabilized pharmaceutical composition, stabilized pharmaceutical composition solution preparation, film-form preparation and method for producing film-form preparation
CN103675271B (en) * 2013-12-23 2016-01-06 北京新华联协和药业有限责任公司 Anaphylactia allergen colloidal gold diagnosis test strips and preparation method thereof
CN114053402A (en) * 2020-08-03 2022-02-18 格林生物医药科技(天津)有限公司 Allergen preparation
CN114588130B (en) * 2020-11-20 2023-07-04 四川好医生攀西药业有限责任公司 Adhesive bandage containing periplaneta americana active ingredient and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions

Also Published As

Publication number Publication date
UA93479C2 (en) 2011-02-25
ZA200505111B (en) 2006-12-27
CN1731979B (en) 2010-05-12
CN1731979A (en) 2006-02-08

Similar Documents

Publication Publication Date Title
MXPA05005528A (en) Pharmaceutical allergen product.
CO5700707A2 (en) PHARMACEUTICAL PRODUCTS
ES2171268T3 (en) FORMULATIONS OF TRAMADOL OF MULTIPLE UNITS.
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
AR027034A1 (en) COMPOSITION FOR ORAL EXTENDED RELEASE DOSE
AR065970A2 (en) A SOLID ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND GLIBENCLAMIDE AND USE OF SUCH COMPOSITION
DE60330322D1 (en) MEDICINES microparticles
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
AR024966A1 (en) PHARMACEUTICAL FORMULATION
UY27455A1 (en) DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CICLOPENTAPIRAZOL -3-IL) - REPLACED. ITS OBTAINING AND USE AS DRUGS.
WO2004075875A8 (en) Dosage form having a saccharide matrix
ATE354362T1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHIC ACTIVE INGREDIENT
DE60102590D1 (en) PHARMACEUTICAL FORMS FOR TREATING ORAL MYCOSIS
ATE291908T1 (en) IBUPROFEN ACTIVE INGREDIENT PREPARATION
AR025060A1 (en) PHARMACEUTICAL FORMULATIONS IN HYDROXYPROPILMETILCELLULOSE CAPSULES
AR042677A1 (en) ORAL CARE COMPOSITIONS AND METHODS
AR066455A2 (en) USE OF N-METHYL-N COMPOUNDS - [(1R) -1-PHENYL-2- (3R) -3-HYDROXIPIRROLIDIN -1-IL - = - ETIL] -2,2-DIFENYL ACETAMIDE TO PRODUCE A MEDICINAL PRODUCT FOR THE TREATMENT OF INTESTINAL NON-INFLAMMATORY DISEASES
ECSP055895A (en) PHARMACEUTICAL ALLERGEN PRODUCT
UY27539A1 (en) PHARMACEUTICAL FORMULATION
AR021086A1 (en) OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT.
AR043418A1 (en) LIQUID FORMULATIONS OF FACTOR UNION PROTEINS TUMOR NECROSIS
GT200400134A (en) EMULSIONING SYSTEMS CONTAINING DERIVATIVES OF AZETIDINE
HRP20080178T3 (en) PHARMACEUTICAL PREPARATION IN THE FORM OF HYDROGEL FOR THE TRANSDERMAL APPLICATION OF ACTIVE SUBSTANCES
BRPI0407850A (en) process for the manufacture of a pharmaceutical composition containing the active ingredient fenofibrate or one of its derivatives, and fenofibrate tablet or one of its derivatives
ATE294181T1 (en) (3,4-A:3,4-C)CARBAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME